Funds and ETFs Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen 15:59:53 22/04/2024 BST 5-day change 1st Jan Change
581.5 DKK -0.34% Intraday chart for Zealand Pharma A/S -2.19% +55.81%
Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
581.5 DKK
Average target price
754.3 DKK
Spread / Average Target
+29.71%
Consensus
  1. Stock Market
  2. Equities
  3. ZEAL Stock
  4. Funds and ETFs Zealand Pharma A/S